Baird’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-53,366
Closed -$5.46M 1383
2014
Q4
$5.46M Sell
53,366
-4,931
-8% -$473K 0.06% 314
2014
Q3
$5.04M Sell
58,297
-3,413
-6% -$302K 0.07% 248
2014
Q2
$5.57M Buy
61,710
+516
+0.8% +$38.6K 0.08% 233
2014
Q1
$4.51M Buy
61,194
+1,054
+2% +$73.5K 0.07% 285
2013
Q4
$4.1M Buy
60,140
+3,096
+5% +$201K 0.07% 298
2013
Q3
$3.48M Sell
57,044
-22,057
-28% -$1.35M 0.06% 325
2013
Q2
$4.41M Buy
+79,101
New +$4.57M 0.09% 261

Baird's COV Position: Q1 2015 in Review

Baird sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 53,366 shares — an estimated $5.46M sold.

Baird first reported a position in COV in Q2 2013 and held it in 7 quarters. The position peaked at $5.57M in Q2 2014. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

  • Baird reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
  • Baird sold 53,366 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $5.46M.
  • Baird first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 7 quarters.
  • Baird's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $5.57M in Q2 2014.
  • 1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.